OHSU

IRB #

IRB00010707

Title

Novel Predictors of Outcome in Hypertrophic Cardiomyopathy (HCMR)

Principal Investigator

Stephen Heitner

Study Purpose

To learn more about abnormal thickening of the heart muscle, called hypertrophic cardiomyopathy (HCM). HCM is passed from parents to a child through genes, the units of DNA (the chemical structure carrying genetic information) that determines characteristics such as eye color, height and whether someone is male or female. One goal of the study is to understand the inheritance of HCM.

Medical Condition(s)

Hypertrophic cardiomyopathy (HCM)
Cardiovascular

Eligibility Criteria

Includes but not limited to:
-Males and females age 18-65
-Established diagnosis of HCM
-No history of heart attack
-No metal placed in the body (such as pacemaker, defibrillator, or pins or plates placed during surgery)
-No stage 3 or 4 chronic kidney disease

Age Range

18 - 65

Healthy Volunteers Needed

No

Duration of Participation

About 5 years

Minors Included

No

Contact

Aynun Naher
Study Coordinator
(503) 494-3313

Sponsor

Funded by the National Heart, Lung and Blood Institute, part of the National Institutes of Health

Recruitment End

05/31/2016

Compensation Provided

No


Go Back